Meet Vitali's collection of GHK-Cu (copper peptide) based products: Your Secret Weapon for Thicker Skin and beyond
Following a second administration of Donor+Cas9, plasma Exe4 levels increased and remained elevated for over 28 weeks, doubling the level of Exe4 production and secretion compared to a single administration, suggesting the potential for fine-tuning the regimen dose through repetitive administration (Supplementary Fig
As an inherent skeptic, I immediately assumed this must be a placebo affect
Wu J, Vodovotz Y, Abdelhamid S, Guyette FX, Yaffe MB, Gruen DS, et al
Importantly, none of the trials in T1D reported an increase in diabetic ketoacidosis (DKA) a key concern that has limited the use of SGLT2 inhibitors in T1D